Read between the lines. Dr. Rauschecker is a gentleman and was being diplomatic, perhaps at his own expense.
Dr. Rauschecker and Susan Shore both did research as part of the Tinnitus Research Consortium between 1998 - 2012. From what I can tell, that was a fairly tight knit group that existed in the US and was funded by a philanthropist who donated over 8 million dollars over a 15 year period. So, I would venture that both are aware of each other's work, and if either leads to a benefit to patients, they will not discount that.
However, bimodal stimulation centers around stimulating the Dorsal Cochlear Nucleus in the brainstem. Dr. Rauschecker acknowledged that there is some evidence that this area of the brain may play a part, but his theory is that tinnitus is more complex. Rather, he says that in addition to hearing loss, areas of the brain within the limbic system are also damaged in some way. His model is that both damage to the "ear" and damage to the limbic system must both exist for tinnitus to occur. If these limbic regions were not damaged, the tinnitus signal would not reach the auditory cortex and we would not "hear it". Therefore, the undamaged limbic structures act as a gating mechanism which nicely explains why not everyone with hearing loss experiences tinnitus. His research centers on understanding the mechanisms at work in the limbic system and this understanding will lead to better treatments and eventually a cure. Here is a very hasty and rough schematic.
View attachment 26127
As far as Neuromod is concerned, I have not heard one thing about it here in the US. The AARP (American Association of Retired Persons) is advertising the Levo System. Nowhere have I seen anything about Neuromod except an ad in the ATA magazine which only talked about their clinical program, which I found strange.
Speaking of AARP, like the Veteran's associations, they are another fairly powerful group in the US when it comes to lobbying. We should keep that in mind.
TC